Our study showed that TDF, which was originally an antiviral drug, was associated with the inhibition of p-PI3K, p-Akt and p-mTOR expression, which led to the downregulation of Bcl-xl and consequently HSC apoptosis to ameliorate liver fibrosis both in vitro and in vivo. Here, BCL2L1 is linked to Hepatic fibrosis.